EP Patent

EP2661273A4 — Pharmaceutical compositions of iron for oral administration

Assigned to Merrion Research Ill Ltd · Expires 2014-06-04 · 12y expired

What this patent protects

Patent listed against octreotide-acetate.

Drugs covered by this patent

Patent Metadata

Patent number
EP2661273A4
Jurisdiction
EP
Classification
—
Expires
2014-06-04
Drug substance claim
No
Drug product claim
No
Assignee
Merrion Research Ill Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.